Correction to "S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of <i>Mycobacterium tuberculosis</i> Cell Envelope".

Singh, Padam; Kumar, Shashi Kant; Maurya, Vineet Kumar; Mehta, Basant Kumar; Ahmad, Hafsa; Dwivedi, Anil Kumar; Chaturvedi, Vinita; Thakur, Tejender S; Sinha, Sudhir

Correction to "S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope".

Singh, Padam; Kumar, Shashi Kant; Maurya, Vineet Kumar; Mehta, Basant Kumar; Ahmad, Hafsa; Dwivedi, Anil Kumar; Chaturvedi, Vinita; Thakur, Tejender S; Sinha, Sudhir.

ACS Omega ; 2(12): 9287, 2017 Dec 31.

Article em En | MEDLINE | ID: mdl-31457441